Natixis Investment Managers International lowered its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 9.1% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 219,638 shares of the medical device company’s stock after selling 22,094 shares during the quarter. DexCom makes up […]
Cibc World Markets Corp raised its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 59.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 105,232 shares of the medical device company’s stock after acquiring an additional […]
Cibc World Markets Corp raised its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 59.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 105,232 shares of the medical device company’s stock after acquiring an additional […]
Eagle Asset Management Inc. grew its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 21.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,756,216 shares of the medical device company’s stock after acquiring an additional 310,728 shares during the […]
DexCom, Inc. (NASDAQ:DXCM – Get Free Report) EVP Michael Jon Brown sold 652 shares of the company’s stock in a transaction on Friday, May 31st. The stock was sold at an average price of $119.24, for a total transaction of $77,744.48. Following the transaction, the executive vice president now owns 67,560 shares of the company’s […]